이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
NUVA 주식 개요
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery.
NuVasive, Inc. 경쟁사
가격 내역 및 성능
| 과거 주가 | |
|---|---|
| 현재 주가 | US$39.75 |
| 52주 최고치 | US$49.53 |
| 52주 최저치 | US$35.17 |
| 베타 | 1.07 |
| 11개월 변경 | -0.63% |
| 3개월 변경 사항 | 0.84% |
| 1년 변경 사항 | -8.30% |
| 33년 변화 | -22.24% |
| 5년 변화 | -42.71% |
| IPO 이후 변화 | 248.68% |
최근 뉴스 및 업데이트
Recent updates
Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Apr 18
What Does NuVasive, Inc.'s (NASDAQ:NUVA) Share Price Indicate?
Jan 24NuVasive, Inc.'s (NASDAQ:NUVA) Intrinsic Value Is Potentially 48% Above Its Share Price
Dec 31Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Dec 05These 4 Measures Indicate That NuVasive (NASDAQ:NUVA) Is Using Debt Reasonably Well
Nov 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Sep 22Capital Allocation Trends At NuVasive (NASDAQ:NUVA) Aren't Ideal
Sep 01NuVasive Likely Undervalued, But It's Hard To Find Catalysts
Aug 17Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Aug 11NuVasive Non-GAAP EPS of $0.47 misses by $0.09, revenue of $310.5M beats by $4.12M
Aug 03NuVasive: Industry Tailwinds More Than Fairly Priced
Jun 13Calculating The Intrinsic Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jun 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
May 11NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Apr 20At US$56.32, Is NuVasive, Inc. (NASDAQ:NUVA) Worth Looking At Closely?
Mar 30NuVasive's Turnaround Story Needs A Boost From Better Results
Mar 01Investors Could Be Concerned With NuVasive's (NASDAQ:NUVA) Returns On Capital
Dec 28Should You Think About Buying NuVasive, Inc. (NASDAQ:NUVA) Now?
Dec 02NuVasive (NASDAQ:NUVA) Has A Pretty Healthy Balance Sheet
Nov 11NuVasive, Inc. (NASDAQ:NUVA) Shares Could Be 32% Below Their Intrinsic Value Estimate
Oct 21Be Wary Of NuVasive (NASDAQ:NUVA) And Its Returns On Capital
Sep 29At US$59.79, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List?
Aug 18NuVasive Still Getting No Love With COVID-19 And Competitive Worries
Aug 12Does NuVasive (NASDAQ:NUVA) Have A Healthy Balance Sheet?
Jul 27Are Investors Undervaluing NuVasive, Inc. (NASDAQ:NUVA) By 21%?
Jun 17Some Investors May Be Worried About NuVasive's (NASDAQ:NUVA) Returns On Capital
May 30Why We Think NuVasive, Inc.'s (NASDAQ:NUVA) CEO Compensation Is Not Excessive At All
May 12Is NuVasive (NASDAQ:NUVA) Using Too Much Debt?
Mar 30Is Now The Time To Look At Buying NuVasive, Inc. (NASDAQ:NUVA)?
Mar 09Need To Know: NuVasive, Inc. (NASDAQ:NUVA) Insiders Have Been Buying Shares
Feb 16
A Look At The Fair Value Of NuVasive, Inc. (NASDAQ:NUVA)
Jan 26NuVasive stock gains on study results of its X360 surgery approach
Jan 06What Type Of Returns Would NuVasive's(NASDAQ:NUVA) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 05주주 수익률
| NUVA | US Medical Equipment | US 마켓 | |
|---|---|---|---|
| 7D | 1.5% | -0.6% | 0.9% |
| 1Y | -8.3% | 20.9% | 32.4% |
수익률 대 산업: NUVA 지난 1년 동안 -0.5 %를 반환한 US Medical Equipment 업계보다 저조한 성과를 냈습니다.
수익률 대 시장: NUVA 지난 1년 동안 23.3 %를 반환한 US 시장보다 저조한 성과를 냈습니다.
가격 변동성
| NUVA volatility | |
|---|---|
| NUVA Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 8.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.2% |
안정적인 주가: NUVA 는) 지난 3개월 동안 큰 가격 변동성이 없었습니다.
시간에 따른 변동성: NUVA 의 주간 변동성( 4% )은 지난 1년 동안 안정적인 모습을 보였습니다.
회사 소개
| 설립 | 직원 | CEO | 웹사이트 |
|---|---|---|---|
| 1997 | 3,000 | Chris Barry | www.nuvasive.com |
NuVasive, Inc. 기본 사항 요약
| NUVA 기본 통계 | |
|---|---|
| 시가총액 | US$2.08b |
| 수익(TTM) | US$28.45m |
| 수익(TTM) | US$1.23b |
73.3x
P/E 비율1.7x
P/S 비율NUVA 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
| NUVA 손익 계산서(TTM) | |
|---|---|
| 수익 | US$1.23b |
| 수익 비용 | US$347.50m |
| 총 이익 | US$878.73m |
| 기타 비용 | US$850.28m |
| 수익 | US$28.45m |
최근 보고된 수익
Jun 30, 2023
다음 수익 날짜
n/a
| 주당 순이익(EPS) | 0.54 |
| 총 마진 | 71.66% |
| 순이익 마진 | 2.32% |
| 부채/자본 비율 | 89.1% |
NUVA 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기